These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22073868)

  • 1. [Role of chemokines/chemokine receptors in pathogenesis of diabetic nephropathy].
    Hara A; Wada T
    Nihon Jinzo Gakkai Shi; 2011; 53(7):1027-33. PubMed ID: 22073868
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemokines as therapeutic targets in renal inflammation.
    Rovin BH
    Am J Kidney Dis; 1999 Oct; 34(4):761-4; discussion 765-7. PubMed ID: 10516362
    [No Abstract]   [Full Text] [Related]  

  • 3. Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy?
    Wada T; Yokoyama H; Matsushima K; Kobayashi K
    Nephrol Dial Transplant; 2003 Mar; 18(3):457-9. PubMed ID: 12584260
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biology in regulation of kidney functions: MCP-1/CCR2].
    Wada T; Yokoyama H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():288-92. PubMed ID: 16523904
    [No Abstract]   [Full Text] [Related]  

  • 6. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
    Parody TR; Stone MJ
    Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.
    Saederup N; Chan L; Lira SA; Charo IF
    Circulation; 2008 Apr; 117(13):1642-8. PubMed ID: 18165355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemokines and chemokine receptors].
    Yoshie O
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():212-7. PubMed ID: 23513839
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
    Boring L; Gosling J; Cleary M; Charo IF
    Nature; 1998 Aug; 394(6696):894-7. PubMed ID: 9732872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines as therapeutic targets in renal disease.
    Holdsworth SR; Kitching AR; Tipping PG
    Curr Opin Nephrol Hypertens; 2000 Sep; 9(5):505-11. PubMed ID: 10990369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of oxidative stress in pathogenesis of diabetic nephropathy].
    Inoguchi T
    Nihon Jinzo Gakkai Shi; 2011; 53(7):1016-20. PubMed ID: 22073866
    [No Abstract]   [Full Text] [Related]  

  • 13. Is dimerization of chemokine receptors functionally relevant?
    Thelen M; Baggiolini M
    Sci STKE; 2001 Oct; 2001(104):pe34. PubMed ID: 11604547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microinflammation in diabetic nephropathy].
    Ogawa D; Shikata K
    Nihon Jinzo Gakkai Shi; 2011; 53(7):1021-6. PubMed ID: 22073867
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemokines and chemokine receptors: multipurpose players in neuroinflammation.
    Ransohoff RM; Liu L; Cardona AE
    Int Rev Neurobiol; 2007; 82():187-204. PubMed ID: 17678962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis.
    Tucci M; Calvani N; Richards HB; Quatraro C; Silvestris F
    Ann N Y Acad Sci; 2005 Jun; 1051():421-32. PubMed ID: 16126984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemokines and chemokine receptors in diabetic nephropathy.
    Ruster C; Wolf G
    Front Biosci; 2008 Jan; 13():944-55. PubMed ID: 17981602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and neuromodulation.
    Mélik-Parsadaniantz S; Rostène W
    J Neuroimmunol; 2008 Jul; 198(1-2):62-8. PubMed ID: 18538863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Szczuciński A; Losy J
    Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
    Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
    Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.